Cargando…
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study
BACKGROUND: In patients with rheumatoid arthritis (RA), qualitative alterations of low and high-density lipoproteins (LDL and HDL, respectively) might partially explain their increased cardiovascular risk. Tocilizumab has been associated with an increase in lipids, including triglyceride (TG) and ch...
Autores principales: | Pierini, Florencia S., Botta, Eliana, Soriano, Enrique R., Martin, Maximiliano, Boero, Laura, Meroño, Tomás, Saez, María Soledad, Lozano Chiappe, Ezequiel, Cerda, Osvaldo, Citera, Gustavo, Gandino, Ignacio, Rosa, Javier, Sorroche, Patricia, Kontush, Anatol, Brites, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217399/ https://www.ncbi.nlm.nih.gov/pubmed/33811316 http://dx.doi.org/10.1007/s40744-021-00304-0 |
Ejemplares similares
-
Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit
por: Brites, Fernando, et al.
Publicado: (2017) -
HDL particle number and size as predictors of cardiovascular disease
por: Kontush, Anatol
Publicado: (2015) -
Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients
por: Tetzlaff, Walter F, et al.
Publicado: (2017) -
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
por: Schekatolina, Svetlana, et al.
Publicado: (2022) -
SAT-050 Growth Hormone Receptor Polymorphism and Its Effects on Clinical and Biochemical Expression in Acromegalic Patients
por: Tetzlaff, Walter, et al.
Publicado: (2019)